Comparison of efficacy and safety of gabapentin and duloxetine in painful diabetic peripheral neuropathy: A systematic review and meta-analysis of randomised controlled trials

Yuan Chun Ko, Che Hsiung Lee, Chung Sheng Wu, Yu Jui Huang

研究成果: 雜誌貢獻文章同行評審

摘要

Background: In patients with diabetes mellitus, painful diabetic peripheral neuropathy (PDPN) is a frequent complication and can cause poor quality of life. We compared the efficacy and safety of duloxetine with those of gabapentin in patients with PDPN through a systematic review and meta-analysis of randomised controlled trials. Materials and Methods: PubMed, Embase and the Cochrane Library were searched for eligible studies published from database inception to January 2021. Visual Analogue Scale (VAS), sleep interference score, Clinical Global Impression of Change (CGIC), Patient Global Impression of Change (PGIC), Diabetic Neuropathy Symptom (DNS) score, Diabetic Neuropathic Examination (DNE) score, Neuropathic Disability Score (NDS) and side effects were used to compare duloxetine and gabapentin in patients with PDPN. Results: Three eligible randomised controlled trials involving 290 patients were included. No significant differences were observed between patients receiving duloxetine and gabapentin with respect to VAS (mean change difference = −1.23, 95% CI, −6.09 to 3.62; P =.62), sleep interference score (mean change difference = 0.42, 95% CI, −0.15 to 1.00; P =.15), CGIC (mean difference = 0.04, 95% CI, −0.11 to 0.20; P =.60), PGIC (mean difference= 0.24, 95% CI, −0.13 to 0.60; P =.21), DNS (mean change difference = 0.14, 95% CI, −0.35 to 0.63; P =.58), DNE (mean change difference = 0.26, 95% CI, −0.35 to 0.86; P =.41) and NDS (mean change difference = 0.30, 95% CI, −0.02 to 0.63; P =.07). Conclusions: No significant differences were observed in the efficacy of duloxetine and gabapentin when treating patients with PDPN.

原文英語
文章編號e14576
期刊International Journal of Clinical Practice
75
發行號11
DOIs
出版狀態已發佈 - 十一月 2021

ASJC Scopus subject areas

  • 醫藥 (全部)

指紋

深入研究「Comparison of efficacy and safety of gabapentin and duloxetine in painful diabetic peripheral neuropathy: A systematic review and meta-analysis of randomised controlled trials」主題。共同形成了獨特的指紋。

引用此